Analyst Price Targets — PRVA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 26, 2026 8:26 pm | Jack Slevin | Jefferies | $32.00 | $24.91 | StreetInsider | Privia Health Group Inc (PRVA) PT Raised to $32 at Jefferies |
| February 26, 2026 7:34 pm | Jessica Tassan | Piper Sandler | $36.00 | $24.91 | StreetInsider | Privia Health Group Inc (PRVA) PT Raised to $36 at Piper Sandler |
| January 9, 2026 12:19 pm | — | RBC Capital | $31.00 | $23.15 | TheFly | Privia Health resumed with an Outperform at RBC Capital |
| January 6, 2026 9:57 am | — | Wolfe Research | $31.00 | $24.14 | StreetInsider | Privia Health Group (PRVA) Reiterated at Market Outperform by Citizens |
| November 12, 2025 12:02 pm | — | Canaccord Genuity | $34.00 | $24.32 | TheFly | Privia Health price target raised to $34 from $32 at Canaccord |
| October 9, 2025 9:49 am | — | Barclays | $22.00 | $24.53 | TheFly | Privia Health price target raised to $22 from $21 at Barclays |
| August 29, 2025 8:41 am | — | JMP Securities | $30.00 | $21.81 | TheFly | Privia Health price target raised to $30 from $29 at Citizens JMP |
| April 15, 2025 9:40 am | Michael Ha | Robert W. Baird | $26.00 | $24.10 | TheFly | Privia Health price target raised to $26 from $24 at Baird |
| February 28, 2025 12:21 pm | — | JMP Securities | $29.00 | $24.97 | TheFly | Privia Health price target raised to $29 from $26 at Citizens JMP |
| February 28, 2025 11:47 am | — | Piper Sandler | $40.00 | $24.97 | TheFly | Privia Health price target raised to $40 from $25 at Piper Sandler |
Latest News for PRVA
The mean of analysts' price targets for Privia Health (PRVA) points to a 25.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Privia Health Group, Inc. (PRVA) Q4 2025 Earnings Call Transcript
Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Privia Health (PRVA) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.03 per share a year ago.
All 2025 Operating and Financial Metrics At or Above High End of Guidance Ranges Full-year 2025 Net Income +59.3% from 2024 Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024 Full-year 2025 Net Cash Provided by Operating Activities of $163.4 Million , +49.5% from 2024; Year-end 2025 Cash Balance of $479.7 Million and No Debt 2026 Guidance Reflects ~20% Adjusted EBITDA Growth at Midpoint ARLINGTON,…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PRVA.
U.S. House Trading
No House trades found for PRVA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.